Meta Analyses Of Global Trials Finds In Favor Of Aromatase Inhibitors

[News]

Two separate meta-analyses of clinical trials from around the world that tested tamoxifen against aromatase inhibitor drugs in postmenopausal women with early breast cancer have each reached the same conclusion: aromatase inhibitors are more effective in preventing breast cancer from coming back. Patients using aromatase inhibitors had more than a 3 percent lower cancer recurrence 6-8 years after diagnosis, compared to women using tamoxifen alone.

More... (http://www.medicalnewstoday.com/articles/132746.php)